Sabrina Lindsey Ergun

Sabrina Lindsey Ergun

Auto-generated profile, based on publicly available information

Sabrina Lindsey Ergun

Princeton University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Cell
Verified
Journal Article
Closed access
SESabrina L. Ergun
Sabrina L. Ergun
DFDaniel Fernandez
Daniel Fernandez
TWThomas M. Weiss
Thomas M. Weiss
LLLingyin Li
Lingyin Li

21 October 2025 in New Phytologist
Verified
Journal Article
Open access
EFEric Franklin
Eric Franklin
LWLianyong Wang
Lianyong Wang
ECEdward Renne Cruz
Edward Renne Cruz
KDKeenan Duggal
Keenan Duggal
SESabrina L. Ergun
Sabrina L. Ergun
MJMartin C. Jonikas
Martin C. Jonikas
Summary: Pyrenoids are algal CO 2 ‐fixing organelles that mediate approximately one‐third of global carbon fixation. Most pyrenoids are traversed by membranes that are thought to supply them with concentrated CO 2 . Despite the critical nature of these membranes for pyrenoid function, they are poorly understood, with few protein components known in any species. Here, we identify protein components of the pyrenoid‐traversing membranes from the leading model alga, Chlamydomonas reinhardtii, by affinity purification and mass spectrometry of membrane fragments. Our proteome includes previously known proteins as well as novel candidates. We further characterize two of the novel pyrenoid‐traversing membrane‐resident proteins: Cre10.g452250, which we name Pyrenoid Membrane Enriched 1 (PME1), and Cre02.g143550, also known as Low‐CO 2 ‐Induced 16 (LCI16). We confirm the pyrenoid‐traversing membrane localization of LCI16 and observe that PME1 and LCI16 physically interact. We find that neither protein is required for normal membrane morphology or growth under CO 2 ‐limiting conditions, but that both mutants show a similar proteomic profile to those of established pyrenoid mutants. Taken together, our study identifies the proteome of the pyrenoid‐traversing membranes and initiates the characterization of a novel pyrenoid‐traversing membrane complex, building toward a mechanistic understanding of the pyrenoid.

12 August 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
RCRebecca Jing Mun Chan
Rebecca Jing Mun Chan
XCXujun Cao
Xujun Cao
SESabrina Lindsey Ergun
Sabrina Lindsey Ergun
ENEvert Njomen
Evert Njomen
SLStephen Russell Lynch
Stephen Russell Lynch
LLLingyin Li
Lingyin Li
The anti-viral and anti-cancer STING innate immune pathway can exacerbate autoimmune and neurodegenerative diseases when aberrantly activated, emphasizing a key unmet need for STING pathway antagonists. However, no such inhibitors have advanced to the clinic because it remains unclear which mechanistic step(s) of human STING activation are crucial for potent and context-independent inhibition of downstream signaling. Here, we report that C91 palmitoylation, the mechanistic target of a potent tool compound, is not universally necessary for human STING signaling, making it a poor target for drug development. Instead, we discover that evolutionarily conserved C64 is basally palmitoylated and is crucial for preventing unproductive STING oligomerization in the absence of cGAMP stimulation. The effects of palmitoylation at C64 and C91 converge on the control of intra-dimer disulfide bond formation at C148. Importantly, we show for the first time that signaling-competent STING oligomers are composed of a mixture of two species: disulfide-linked STING dimers that stabilize the oligomer, and reduced STING dimers that are phosphorylated to actuate interferon signaling. Given this complex landscape and cell type specificity of palmitoylation modifications, we conclude that robust STING inhibitors must directly inhibit the oligomerization process. Taking inspiration from STING’s natural autoinhibitory mechanism, we identified an eight amino acid peptide that binds a defined pocket at the inter-dimer oligomerization interface as a proof-of-concept human STING inhibitor, setting the stage for future therapeutic development. Summary: We report that functional STING oligomers require palmitoylation at cysteine 64 and some proportion of reduced dimers, and define the site of autoinhibition that can be targeted to disrupt STING oligomerization and activity.

10 October 2025 in bioRxiv
Verified
Preprint
Open access
SHShan He
Shan He
LLLinnea M. Lemma
Linnea M. Lemma
AMAlejandro Martinez-Calvo
Alejandro Martinez-Calvo
GHGuanhua He
Guanhua He
JHJessica H. Hennacy
Jessica H. Hennacy
MJMartin C. Jonikas
Martin C. Jonikas
Biomolecular condensates spatially organize cellular functions, but the regulation of their size, number, dissolution, and re-condensation is poorly understood. The pyrenoid, an algal biomolecular condensate that mediates one-third of global CO 2 fixation, typically exists as one large condensate per chloroplast, but during cell division it transiently dissolves and reconfigures into multiple smaller condensates. Here, we identify a kinase, KEY1, in the model alga Chlamydomonas reinhardtii that regulates pyrenoid condensate size and number dynamics throughout the cell cycle and is necessary for normal pyrenoid function and growth. Unlike wild type, key1 mutant cells have multiple smaller condensates throughout the cell cycle that fail to dissolve during cell division. We show that KEY1 localizes to the condensates and promotes their dissolution by disrupting interactions between their core constituents, the CO 2 -fixing enzyme Rubisco and its linker protein EPYC1, through EPYC1 phosphorylation. We develop a biophysical model that recapitulates KEY1-mediated condensate size and number regulation and suggests a mechanism for controlling condensate position. These data provide a foundation for the mechanistic understanding of the regulation of size, number, position, and dissolution in pyrenoids and other biomolecular condensates.

10 June 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SESabrina L. Ergun
Sabrina L. Ergun
CDClaire Dignazio
Claire Dignazio
JBJonathan Bouvette
Jonathan Bouvette
HWHaoyu Wu
Haoyu Wu
EFEric Franklin
Eric Franklin
MJMartin C. Jonikas
Martin C. Jonikas
How membranes are integrated into biomolecular condensates is a fundamental question in cell biology. In the algal pyrenoid, an organelle responsible for one-third of global carbon fixation, CO2-delivering thylakoid membranes must penetrate a phase-separated condensate of the CO2-fixing enzyme Rubisco, but the mechanism governing membrane recruitment into the condensate remains unknown. Here, we demonstrate that the Chlamydomonas reinhardtii protein MITH1 acts as a molecular anchor that brings membrane into the pyrenoid condensate. MITH1 dimerizes into an extended coiled coil with an N-terminal amphipathic helix that binds thylakoid membrane. The coiled coil contains multiple novel binding sites for the Rubisco large subunit, allowing the condensate to wet onto the membrane. The coiled coil extends away from the membrane and promotes membrane organization within the condensate. These findings solve a longstanding mechanistic question in pyrenoid biogenesis and reveal general principles for how membranes are integrated into biological condensates.

31 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
EFEric Franklin
Eric Franklin
LWLianyong Wang
Lianyong Wang
ECEdward Renne Cruz
Edward Renne Cruz
KDKeenan Duggal
Keenan Duggal
SESabrina L. Ergun
Sabrina L. Ergun
MJMartin C. Jonikas
Martin C. Jonikas
Summary: Pyrenoids are algal CO 2 -fixing organelles that mediate approximately one-third of global carbon fixation. Most pyrenoids are traversed by membranes that are thought to supply them with concentrated CO 2 . Despite the critical nature of these membranes for pyrenoid function, they are poorly understood, with few protein components known in any species. Here, we identify protein components of the pyrenoid-traversing membranes from the leading model alga, Chlamydomonas reinhardtii, by affinity purification and mass spectrometry of membrane fragments. Our proteome includes previously-known proteins as well as novel candidates. We further characterize two of the novel pyrenoid-traversing membrane-resident proteins: Cre10.g452250, which we name Pyrenoid Membrane Enriched 1 (PME1), and Cre02.g143550, also known as Low-CO 2 -Induced 16 (LCI16). We confirm the pyrenoid-traversing membrane localization of LCI16 and observe that PME1 and LCI16 physically interact. We find that neither protein is required for normal membrane morphology or growth under CO 2 -limiting conditions, but that both mutants show a similar proteomic profile to those of established pyrenoid mutants. Taken together, our study identifies the proteome of the pyrenoid-traversing membranes and initiates the characterization of a novel pyrenoid-traversing membrane complex, building toward a mechanistic understanding of the pyrenoid.